CD274 and leukemia: Conversely, miR-34a overexpression inhibited upregulation of PD-L1 surface and intracellular protein by arsenic trioxide, a chemopreventative agent used in conjunction with All-Trans Retinoic Acid (ATRA) to treat leukemia [87].